Precursor Cell Biology and the Development of Astrocyte Transplantation Therapies: Lessons from Spinal Cord Injury

Neurotherapeutics

Volumn 8, Issue 4, 2011, Pages 677-693

  Noble, Mark ^a   Davies, Jeannette E ^b   Mayer Pröschel, Margot ^a   Pröschel, Christoph ^a   Davies, Stephen J A ^b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Astrocyte heterogeneity; Astrocyte transplantation therapy; Glial precursor cell derived astrocyte; Glial restricted precursor cells; Regeneration; Spinal cord injury

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CILIARY NEUROTROPHIC FACTOR;

ASTROCYTE; CELL HETEROGENEITY; CELL LINEAGE; CELL REGENERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CYTOLOGY; HUMAN; INJURY; NERVE CELL; NEUROLOGIC DISEASE; NEUROPATHIC PAIN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; STEM CELL; TISSUE STRUCTURE;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; HUMANS; RATS; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 80955142102     PISSN: 19337213     EISSN: 18787479     Source Type: Journal    
DOI: 10.1007/s13311-011-0071-z     Document Type: Review

References (152)

1. Noble M, Seang JF, Cohen J. Glia are a unique substrate for the in vitro growth of central nervous system neurons. J Neurosci 1984; 4: 1892-903.
2. Fallon JR. Preferential outgrowth of central nervous system neurites on astrocytes and Schwann cells as compared with nonglial cells in vitro. J Cell Biol 1985; 100: 198-207.
3. Qian JA, Bull MS, Levitt P. Target-derived astroglia regulate axonal outgrowth in a region-specific manner. Dev Biol 1992; 149: 278-294.
4. Buard I, et al. Glial cells promote dendrite formation and the reception of synaptic input in Purkinje cells from postnatal mice. Glia 2010; 58: 538-545.
5. Steinmetz CC, et al. Regional variations in the glial influence on synapse development in the mouse CNS. J Physiol 2006; 577(pt 1): 249-261.
6. Learte AR, Hidalgo A. The role of glial cells in axon guidance, fasciculation and targeting. Adv Exp Med Biol 2007; 621: 156-166.
7. Abbott NJ, Ronnback L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006; 7: 41-53.
8. Araque A, Navarrete M. Glial cells in neuronal network function. Philos Trans R Soc Lond B Biol Sci 2010; 365: 2375-2381.
9. Bentz K, et al. Neural differentiation of embryonic stem cells is induced by signalling from non-neural niche cells. Cell Physiol Biochem 2006; 18: 275-286.
10. Fellin T. Communication between neurons and astrocytes: relevance to the modulation of synaptic and network activity. J Neurochem 2009; 108: 533-544.
11. Fellin T, Carmignoto G. Neurone-to-astrocyte signalling in the brain represents a distinct multifunctional unit. J Physiol 2004; 559(pt 1): 3-15.
12. Fiacco TA, McCarthy KD. Astrocyte calcium elevations: properties, propagation, and effects on brain signaling. Glia 2006; 54: 676-690.
13. Freeman MR. Specification and morphogenesis of astrocytes. Science 2010; 330: 774-778.
14. Giaume C, et al. Astroglial networks: a step further in neuroglial and gliovascular interactions. Nat Rev Neurosci 2010; 11: 87-99.
15. Haseloff RF, et al. In search of the astrocytic factor(s) modulating blood-brain barrier functions in brain capillary endothelial cells in vitro. Cell Mol Neurobiol 2005; 25: 25-39.
16. Haydon PG, Carmignoto G. Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 2006; 86: 1009-1031.
17. Kimelberg HK. Functions of mature mammalian astrocytes: a current view. Neuroscientist 2010; 16: 79-106.
18. Kimelberg HK, Nedergaard M. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 2010; 7: 338-353.
19. Koehler RC, Gebremedhin D, Harder DR. Role of astrocytes in cerebrovascular regulation. J Appl Physiol 2006; 100: 307-317.
20. Nedergaard M, Ransom B, Goldman SA. New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci 2003; 26: 523-530.
21. Seifert G, Schilling K, Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat Rev Neurosci 2006; 7: 194-206.
22. Simard M, Nedergaard M. The neurobiology of glia in the context of water and ion homeostasis. Neuroscience 2004; 129: 877-896.
23. Okada S, et al. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 2006; 12: 829-834.
24. Sahni V, et al. BMPR1a and BMPR1b signaling exert opposing effects on gliosis after spinal cord injury. J Neurosci 2010; 30: 1839-1855.
25. Groves AK, et al. Repair of demyelinated lesions by transplantation of purified O-2A progenitor cells. Nature 1993; 362: 453-455.
26. Warrington AE, Barbarese E, Pfeiffer SE. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res 1993; 34: 1-13.
27. Jeffery N, et al. Behavioural consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord. Eur. J Neurosci 1999: xx: 1508-1514.
28. Honmou O, et al. Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J. Neurosci 1996; 16: 3199-3208.
29. Utzschneider DA, et al. Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc Natl Acad Sci USA 1994: xx: 53-57.
30. Liu S, et al. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci USA 2000; 97: 6126-6131.
31. Windrem MS, et al. Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J Neurosci Res 2002; 69: 966-975.
32. Windrem MS, et al. Neonatal chimerization with human glial progenitor cells can both remyelinate and rescue the otherwise lethally hypomyelinated shiverer mouse. Cell Stem Cell 2008; 2: 553-565.
33. Windrem MS, et al. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med 2004; 10: 93-7.
34. Learish RD, et al. Intraventricular transplantation of oligodendrocyte progenitors into a fetal myelin mutant results in widespread formation of myelin. Ann Neurol 1999; 46: 716-722.
35. Perez-Bouza A, Glaser T, Brustle O. ES cell-derived glial precursors contribute to remyelination in acutely demyelinated spinal cord lesions. Brain Pathol 2005; 15: 208-216.
36. Cloutier F, et al. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm. Regen Med 2006; 1: 469-479.
37. Brustle O, et al. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999; 285: 754-756.
38. Zhang SC, Lipsitz D, Duncan ID, Self-renewing canine oligodendroglial progenitor expanded as oligospheres. J Neurosci Res 1998; 54: 181-190.
39. Davies JE, et al. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol 2006; 5: 7.
40. Davies JE, et al. Transplanted astrocytes derived from BMP or CNTF treated glial restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J Biol 2008; 7: e24.
41. Davies SJA, et al. Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS ONE 2011; 6: e17328.
42. Bignami A, et al. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res 1972; 43: 429-435.
43. Brenner M, et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001; 27: 117-120.
44. Rodriguez D, et al. Infantile Alexander disease: spectrum of GFAP mutations and genotype-phenotype correlation. Am J Hum Genet 2001; 69: 1134-1140.
45. Li R, et al. GFAP mutations in Alexander disease. Int J Dev Neurosci 2002; 20: 259-268.
46. Dietrich J, et al. EIF2B5 mutations compromise GFAP(+) astrocyte generation in vanishing white matter leukodystrophy. Nat Med 2005; 11: 277-283.
47. Nagai M, et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007; 10: 615-622.
48. Ouyang YB, et al. Overexpression of inducible heat shock protein 70 and its mutants in astrocytes is associated with maintenance of mitochondrial physiology during glucose deprivation stress. Cell Stress Chaperones 2006; 11: 180-186.
49. Seifert G, Carmignoto G, Steinhauser C. Astrocyte dysfunction in epilepsy. Brain Res Rev 2010; 63: 212-221.
50. Bradford J, et al. Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms. Proc Natl Acad Sci U S A 2009; 106: 22480-22485.
51. Bradford J, et al. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. J Biol Chem 2010; 285: 10653-10661.
52. Xu L, Zeng LH, Wong M. Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex. Neurobiol Dis 2009; 34: 291-299.
53. Maezawa I, et al. Rett syndrome astrocytes are abnormal and spread MeCP2 deficiency through gap junctions. J Neurosci 2009; 29: 5051-5061.
54. Cui M, et al. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A 2009; 106: 8043-8048.
55. Rappold PM, Tieu K. Astrocytes and therapeutics for Parkinson's disease. Neurotherapeutics 2010; 7: 413-423.
56. Seifert G, et al. Enhanced relative expression of glutamate receptor 1 flip AMPA receptor subunits in hippocampal astrocytes of epilepsy patients with Ammon's horn sclerosis. J Neurosci 2004; 24: 1996-2003.
57. Windle WF, Clemente CD, Chambers WW. Inhibition of formation of a glial barrier as a means of permitting a peripheral nerve to grow into the brain. J omp Neurol 1952; 96: 359-369.
58. McKeon RJ, Höke A, Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol 1995; 136: 32-43.
59. McKeon RJ, Jurynec MJ, Buck CR. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J Neurosci 1999; 19: 10778-10788.
60. Davies SJ, Field PM, Raisman G. Regeneration of cut adult axons fails even in the presence of continuous aligned glial pathways. Exp Neurol 1996; 142: 203-216.
61. Davies S, et al. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 1999; 19: 5810-5822.
62. Groves AK, et al. The characterization of astrocyte cell lines that display properties of glial scar tissue. Dev Biol 1993; 159: 87-104.
63. Buss A, et al. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury. BMC Neurol 2009; 9: 32.
64. Morgenstern DA, Asher RA, Fawcett JW. Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res 2002; 137: 313-332.
65. Sandvig A, et al. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004; 46: 225-251.
66. Jones LL, Margolis RU, Tuszynski MH. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 2003; 182: 399-411.
67. Krautstrunk M, et al. Increased expression of the putative axon growth-repulsive extracellular matrix molecule, keratan sulphate proteoglycan, following traumatic injury of the adult rat spinal cord. Acta Neuropathol 2002; 104: 592-600.
68. Tang X, Davies JE, Davies SJ. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 2003; 71: 427-444.
69. Ard MD, et al. Growth and degeneration of axons on astrocyte surfaces: effects on extracellular matrix and on later axonal growth. Glia 1993; 9: 248-259.
70. Wang LC, et al. Astroglial differentiation is required for support of neurite outgrowth. J Neurosci 1994; 14(5 pt 2): 3195-3207.
71. Lu SY, et al. Effect of fetal striatal and astrocyte transplants into unilateral excitotoxin-lesioned striatum. J Neural Transplant Plast 1993; 4: 279-287.
72. Bradbury EJ, et al. Astrocyte transplants alleviate lesion induced memory deficits independently of cholinergic recovery. Neuroscience 1995; 65: 955-972.
73. Joosten EA, Veldhuis WB, Hamers FP. Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury. J Neurosci Res 2004; 77: 127-142.
74. McCarthy K, Vellis JD. Preparation of seperate astroglial and oligodendroglial cultures from rat cerebral tissue. J Cell Biol 1980; 85: 890-902.
75. Noble M, Murray K. Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J 1984; 3: 2243-2247.
76. Smith GM, et al. Maturation of astrocytes in vitro alters the extent and molecular basis of neurite outgrowth. Dev Biol 1990; 138: 377-390.
77. Rao MS. Multipotent and restricted precursors in the central nervous system. Anat Rec 1999; 257: 137-148.
78. Noble M, Pröschel C, Mayer-Proschel M. Getting a GR(i)P on oligodendrocyte development. Dev Biol 2004; 265: 33-52.
79. Rao M, Mayer-Pröschel M. Glial restricted precursors are derived from multipotent neuroepithelial stem cells. Dev Biology 1997; 188: 48-63.
80. Rao M, Noble M, Mayer-Pröschel M. A tripotential glial precursor cell is present in the developing spinal cord. Proc Natl Acad Sci U S A 1998; 95: 3996-4001.
81. Mayer-Pröschel M, et al. Isolation of lineage-restricted neuronal precursors from multipotent neuroepithelial stem cells. Neuron 1997; 19: 773-785.
82. Maragakis NJ, et al. Glutamate transporter expression and function in human glial progenitors. Glia 2004; 45: 133-143.
83. Walczak P, et al. Human glial-restricted progenitors survive, proliferate, and preserve electrophysiological function in rats with focal inflammatory spinal cord demyelination. Glia 2011; 59: 499-510.
84. Jin Y, et al. Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury. J Neurotrauma 2011; 28:(in press).
85. Hill CE, et al. Acute transplantation of glial restricted precursor cells into spinal cord contusion injuries: survival, differentiation and effects on lesion environment and axonal regeneration. Exp Neurol 2004; 190: 289-310.
86. Herrera J, et al. Embryonic-derived glial-restricted precursor cells (GRP cells) can differentiate into astrocytes and oligodendrocytes in vivo. Exp. Neurol 2001; 171: 11-21.
87. Cao Q, et al. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 2005; 25: 6947-6957.
88. Nout YS, et al. Glial restricted precursor cell transplant with cyclic adenosine monophosphate improved some autonomic functions but resulted in a reduced graft size after spinal cord contusion injury in rats. Exp Neurol 2011; 227: 159-171.
89. Alexanian AR, et al. Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia. Cytotherapy 2010; 13: 61-68.
90. Wu DC, et al. Glial cell response: A pathogenic factor in Parkinson's disease. J Neurovirol 2002; 8: 551-558.
91. Lepore AC, Fischer I. Lineage-restricted neural precursors survive, migrate, and differentiate following transplantation into the injured adult spinal cord. Exp Neurol 2005; 194: 230-242.
92. Sandrock W, et al. Isolation, characterization and preclinical development of human glial-restricted progenitor cells for treatment of neurological disorders. Regen Med 2010; 5: 381-394.
93. Mujtaba J, et al. Lineage restricted precursors can be isolated from both the mouse neural tube and cultured ES cells. Dev Biol 1999; 214: 113-127.
94. Dietrich J, Noble M, Mayer-Proschel M. Characterization of A2B5+ glial precursor cells from cryopreserved human fetal brain progenitor cells. Glia 2002; 40: 65-77.
95. Raff MC, et al. Two types of astrocytes in cultures of developing rat white matter: differences in morphology, surface gangliosides, and growth characteristics. J Neurosci 1983; 3: 1289-1300.
96. Raff MC, Miller RH, Noble M. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on the culture medium. Nature 1983; 303: 390-396.
97. Raff MC, Abney ER, Miller RH. Two glial cell lineages diverge prenatally in rat optic nerve. Dev Biol 1984; 106: 53-60.
98. Strathmann FG, Wang X, Mayer-Proschel M. Identification of two novel glial-restricted cell populations in the embryonic telencephalon arising from unique origins. BMC Dev Biol 2007; 7: 33.
99. Mayer M, Bhakoo K, Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994; 120: 142-153.
100. Barres B, et al. Ciliary neurotrophic factor enhances the rate of oligodendrocyte generation. Mol Cell Neurosci 1996; 8: 146-156.
101. Marmur R, et al. Differentiation of oligodendroglial progenitors derived from cortical multipotent cells requires extrinsic signals including activation of gp130/LIFbeta receptors. J Neurosci 1998; 18: 9800-9811.
102. Espinosa de los Monteros A, Zhang M, De Vellis J. O2A progenitor cells transplanted into the neonatal rat brain develop into oligodendrocytes but not astrocytes. Proc Natl Acad Sci U S A 1993; 90: 50-54.
103. Blakemore WF, et al. Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS. Glia 2002; 38: 155-168.
104. Keirstead HS, et al. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 2005; 25: 4694-4705.
105. Gregori N, et al. The tripotential glial-restricted precursor (GRP) cell and glial development in the spinal cord: Generation of bipotential oligodendrocyte-type-2 astrocyte progenitor cells and dorsal-ventral differences in GRP cell function. J Neurosci 2002; 22: 248-256.
106. Hill CE, et al. Transplantation of glial restricted precursor cells into acute spinal cord contusion injuries. Soc Neurosci Abs 2001; xx: xx-xx.
107. Mitsui T, et al. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J Neurosci 2005; 25: 9624-9636.
108. Hofstetter CP, et al. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 2002; 8: 346-353.
109. Macias MY, et al. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp Neurol 2006; 201: 335-348.
110. Gömöri E, et al. Fetal development of membrane water channel proteins aquaporin-1 and aquaporin-4 in the human brain. Int. J Dev Neurosci 2006; 24: 295-305.
111. Haglid KG, et al. Cellular and subcellular distribution of the S-100 protein in rabbit and rat central nervous system. J Neurosci Res 1976; 2: 175-91.
112. Ludwin SK, Kosek JC, Eng LF The topographical distribution of S-100 and GFA proteins in the adult rat brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies. J Comp Neurol 1976; 165: 197-207.
113. Rash JE, et al. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci U S A 1998; 95: 11981-11986.
114. Badaut J, et al. Distribution of Aquaporin 9 in the adult rat brain: preferential expression in catecholaminergic neurons and in glial cells. Neuroscience 2004; 128: 27-38.
115. Ochalski PA, et al. Connexin-43 in rat spinal cord: localization in astrocytes and identification of heterotypic astro-oligodendrocytic gap junctions. Neuroscience 1997; 76: 931-945.
116. Lee SS, et al. Characterization of the two genes differentially expressed during development in human fetal astrocytes. Yonsei Med J 2003; 44: 1059-1068.
117. Rothstein JD, et al. Localization of neuronal and glial glutamate transporters. Neuron 1994; 13: 713-725.
118. Cassiani-Ingoni R, et al. Cytoplasmic translocation of Olig2 in adult glial progenitors marks the generation of reactive astrocytes following autoimmune inflammation. Exp Neurol 2006; 201: 349-358.
119. Chen Y, et al. The basic helix-loop-helix transcription factor olig2 is critical for reactive astrocyte proliferation after cortical injury. J Neurosci 2008; 28: 10983-10989.
120. Massey JM et al. Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol 2008; 209: 426-445.
121. Zhao JW, et al. Astrocytes and oligodendrocytes can be generated from NG2+ progenitors after acute brain injury: intracellular localization of oligodendrocyte transcription factor 2 is associated with their fate choice. Eur J Neurosci 2009; 29: 1853-1869.
122. Muir GD, Whishaw IQ. Red nucleus lesions impair overground locomotion in rats: a kinetic analysis. Eur J Neurosci 2000; 12: 1113-1122.
123. Schucht P, et al. Anatomical correlates of locomotor recovery following dorsal and ventral lesions of the rat spinal cord. Exp Neurol 2002; 176: 143-153.
124. Kobayashi NR, et al. BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J Neurosci 1997; 17: 9583-9595.
125. Asher RA, et al. Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J Neurosci 2000; 20: 2427-2438.
126. Davies SJ, et al. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997; 390: 680-683.
127. Bernstein JJ, Goldberg WJ. Rapid migration of grafted cortical astrocytes from suspension grafts placed in host thoracic spinal cord. Brain Res 1989; 491: 205-211.
128. Bernstein JJ, Goldberg WJ. Grafted fetal astrocyte migration can prevent host neuronal atrophy: comparison of astrocytes from cultures and whole piece donors. Restor Neurol Neurosci 1991; 2: 261-270.
129. Goldberg WJ, Bernstein JJ. Transplant-derived astrocytes migrate into host lumbar and cervical spinal cord after implantation of E14 fetal cerebral cortex into adult thoracic spinal cord. J Neurosci Res 1987; 17: 391-403.
130. Buffo A, et al. Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair. Proc Natl Acad Sci USA 2005; 102: 18183-18188.
131. Magnus T, et al. Evidence that nucleocytoplasmic Olig2 translocation mediates brain-injury-induced differentiation of glial precursors to astrocytes. J Neurosci Res 2007; 85: 2126-2137.
132. Alonso G. NG2 proteoglycan-expressing cells of the adult rat brain: possible involvement in the formation of glial scar astrocytes following stab wound. Glia 2005; 49: 318-338.
133. Wolswijk G, Noble M. Identification of an adult-specific glial progenitor cell. Development 1989; 105: 387-400.
134. Wolswijk G, Riddle PN, Noble M. Coexistence of perinatal and adult forms of a glial progenitor cell during development of the rat optic nerve. Development 1990; 109: 691-698.
135. adult progenitor cells. Glia 1991; 4: 495-503.
136. Crang AJ, Gilson J, Blakemore WF. The demonstration by transplantation of the very restricted remyelinating potential of post-mitotic oligodendrocytes. J Neurocytol 1998; 27: 541-553.
137. Autillo-Touati A, et al. Region-specific neuro-astroglial interactions: ultrastructural study of the in vitro expression of neuronal polarity. J Neurosci Res 1988; 19: 326-342.
138. Rousselet A, et al. In vitro regulation of neuronal morphogenesis and polarity by astrocyte-derived factors. Dev Biol 1990; 137: 33-45.
139. Rousselet A, et al. Rat mesencephalic neurons in cuture exhibit different morphological traits in the presence of media conditioned on mesencephalic or striatal astroglia. Dev Biol 1988; 129: 495-504.
140. Oberheim NA, et al. Astrocytic complexity distinguishes the human brain. Trends Neurosci 2006; xx: 547-553.
141. Wang DD, Bordey A. The astrocyte odyssey. Prog Neurobiol 2008; 86: 342-367.
142. Hewett JA. Determinants of regional and local diversity within the astroglial lineage of the normal central nervous system. J Neurochem 2009; 110: 1717-1736.
143. Garcia-Marques J, et al. Different astroglia permissivity controls the migration of olfactory bulb interneuron precursors. Glia 2010; 58: 218-230.
144. Horii-Hayashi N, et al. Chondroitin sulfate demarcates astrocytic territories in the mammalian cerebral cortex. Neurosci Lett 2010; 483: 67-72.
145. White RE, McTigue DM, Jakeman LB. Regional heterogeneity in astrocyte responses following contusive spinal cord injury in mice. J Comp Neurol 2010; 518: 1370-1390.
146. Zhang Y, Barres BA. Astrocyte heterogeneity: an underappreciated topic in neurobiology. Curr Opin Neurobiol 2010; 20: 588-594.
147. Fitting S, et al. Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. J Proteome Res 2010; 9: 1795-1804.
148. Matyash V, Kettenmann H. Heterogeneity in astrocyte morphology and physiology. Brain Res Rev 2010; 63: 2-10.
149. Mika J, et al. Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain. Neuroscience 2010; 165: 1420-1428.
150. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007; 10: 1361-1368.
151. Vallejo R, et al. The role of glia and the immune system in the development and maintenance of neuropathic pain. Pain Pract 2010; 10: 167-184.
152. Watkins LR, Maier SF. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol Rev 2002; 82: 981-1011.